Tenet Healthcare (THC) EBIT (2009 - 2026)

Tenet Healthcare has disclosed EBIT across 18 years of filings, most recently posting $1.3 billion for Q1 2026.

• EBIT for Q1 2026 came in at $1.3 billion, up 37.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 billion (up 6.83% YoY), and the FY2025 annual result was $3.5 billion, down 41.1% from the prior year.
• EBIT came in at $1.3 billion for Q1 2026 at Tenet Healthcare, up from $853.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $3.3 billion in Q1 2024 to a low of $536.0 million in Q4 2022.
• The 5-year median for EBIT is $761.0 million (2024), against an average of $917.8 million.
• Across the five-year window, EBIT soared 444.78% in 2024 and slumped 71.29% in 2025, its largest moves.
• Tenet Healthcare's EBIT stood at $536.0 million in 2022, then jumped by 37.13% to $735.0 million in 2023, then increased by 11.7% to $821.0 million in 2024, then gained by 3.9% to $853.0 million in 2025, then jumped by 51.93% to $1.3 billion in 2026.
• The last three EBIT figures came in at $1.3 billion (Q1 2026), $853.0 million (Q4 2025), and $889.0 million (Q3 2025), per Business Quant data.